| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Journal of Lipid Research, Vol 35, 1918-1924, Copyright © 1994 by Lipid Research, Inc.
ARTICLES |
M Chen, JL Breslow, W Li and T Leff
Department of Biotechnology, Parke-Davis, Ann Arbor, MI 48105.
Insulin-dependent diabetes mellitus (IDDM) is associated with elevated plasma triglyceride levels that normalize after insulin administration. The observation that overexpression of the apoC-III gene in transgenic mice can cause hypertriglyceridemia and other evidence implicating apoC- III in the regulation of triglyceride levels prompted us to examine whether apoC-III might be involved in the hypertriglyceridemia associated with IDDM. To this end, the regulation of apoC-III gene expression was studied in the streptozotocin-treated mouse model of IDDM. In the insulin-deficient diabetic state, these mice have elevated glucose and triglyceride levels and a 1.4- to 1.5-fold increase in hepatic apoC-III mRNA levels, by Northern analysis as well as quantitative solution hybridization RNase protection assay. Insulin treatment normalized the glucose and triglyceride levels and diminished hepatic apoC-III mRNA levels by 59%. Analysis of transcription rates using the nuclear run-on technique demonstrated that the changes in hepatic apoC-III mRNA levels were the results of changes in the transcriptional activity of the gene. To determine the role of insulin in the regulation of apoC-III transcription, HepG2 cells were transfected with an apoC-III reporter construct, and treated with different insulin concentrations. The results demonstrated that insulin treatment induced a dose-dependent down-regulation of apoC-III transcriptional activity. These data suggest that the apoC-III transcriptional changes seen in animals are caused by differences in insulin concentrations. Assuming that apoC-III mRNA levels reflect the synthesis and secretion of the protein, these results present the possibility that overexpression of the apoC-III gene could contribute to the hypertriglyceridemia observed in IDDM.
CiteULike 
Complore 
Connotea 
Del.icio.us 
Digg 
Reddit 
Technorati What's this?
This article has been cited by other articles:
|
|
 |
|
  J. Rhee, H. Ge, W. Yang, M. Fan, C. Handschin, M. Cooper, J. Lin, C. Li, and B. M. Spiegelman Partnership of PGC-1{alpha} and HNF4{alpha} in the Regulation of Lipoprotein Metabolism J. Biol. Chem., May 26, 2006; 281(21): 14683 - 14690. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. A. Ruiz-Narvaez, Y. Yang, Y. Nakanishi, J. Kirchdorfer, and H. Campos APOC3/A5 haplotypes, lipid levels, and risk of myocardial infarction in the Central Valley of Costa Rica J. Lipid Res., December 1, 2005; 46(12): 2605 - 2613. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J.-M. Guettier, A. Georgopoulos, M. Y. Tsai, V. Radha, S. Shanthirani, R. Deepa, M. Gross, G. Rao, and V. Mohan Polymorphisms in the Fatty Acid-Binding Protein 2 and Apolipoprotein C-III Genes Are Associated with the Metabolic Syndrome and Dyslipidemia in a South Indian Population J. Clin. Endocrinol. Metab., March 1, 2005; 90(3): 1705 - 1711. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C.-C. Wei, D.-F. Guo, S.-L. Zhang, J. R. Ingelfinger, and J. S.D. Chan Heterogenous Nuclear Ribonucleoprotein F Modulates Angiotensinogen Gene Expression in Rat Kidney Proximal Tubular Cells J. Am. Soc. Nephrol., March 1, 2005; 16(3): 616 - 628. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Nowak, A. Helleboid-Chapman, H. Jakel, G. Martin, D. Duran-Sandoval, B. Staels, E. M. Rubin, L. A. Pennacchio, M.-R. Taskinen, J. Fruchart-Najib, et al. Insulin-Mediated Down-Regulation of Apolipoprotein A5 Gene Expression through the Phosphatidylinositol 3-Kinase Pathway: Role of Upstream Stimulatory Factor Mol. Cell. Biol., February 15, 2005; 25(4): 1537 - 1548. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 O. Olivieri, N. Martinelli, M. Sandri, A. Bassi, P. Guarini, E. Trabetti, F. Pizzolo, D. Girelli, S. Friso, P. F. Pignatti, et al. Apolipoprotein C-III, n-3 Polyunsaturated Fatty Acids, and "Insulin-Resistant" T-455C APOC3 Gene Polymorphism in Heart Disease Patients: Example of Gene-Diet Interaction Clin. Chem., February 1, 2005; 51(2): 360 - 367. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. S. Cohn, B. W. Patterson, K. D. Uffelman, J. Davignon, and G. Steiner Rate of Production of Plasma and Very-Low-Density Lipoprotein (VLDL) Apolipoprotein C-III Is Strongly Related to the Concentration and Level of Production of VLDL Triglyceride in Male Subjects with Different Body Weights and Levels of Insulin Sensitivity J. Clin. Endocrinol. Metab., August 1, 2004; 89(8): 3949 - 3955. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Juntti-Berggren, E. Refai, I. Appelskog, M. Andersson, G. Imreh, N. Dekki, S. Uhles, L. Yu, W. J. Griffiths, S. Zaitsev, et al. Apolipoprotein CIII promotes Ca2+-dependent {beta} cell death in type 1 diabetes PNAS, July 6, 2004; 101(27): 10090 - 10094. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O. Olivieri, A. Bassi, C. Stranieri, E. Trabetti, N. Martinelli, F. Pizzolo, D. Girelli, S. Friso, P. F. Pignatti, and R. Corrocher Apolipoprotein C-III, metabolic syndrome, and risk of coronary artery disease J. Lipid Res., December 1, 2003; 44(12): 2374 - 2381. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. A. Berti, A. C. Casquero, P. R. Patricio, E. J. B. Bighetti, E. M. Carneiro, A. C. Boschero, and H. C. F. Oliveira Cholesteryl ester transfer protein expression is down-regulated in hyperinsulinemic transgenic mice J. Lipid Res., October 1, 2003; 44(10): 1870 - 1876. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. R. Blackett, R. Germany, B. Sambo, and P. Alaupovic Apolipoprotein C-III Bound to Apolipoprotein B-containing Lipoproteins in Obese Girls Clin. Chem., February 1, 2003; 49(2): 303 - 306. [Full Text] [PDF]
|
|
|
|
|
|
E. Raspe, H. Duez, A. Mansen, C. Fontaine, C. Fievet, J.-C. Fruchart, B. Vennstrom, and B. Staels Identification of Rev-erb{alpha} as a physiological repressor of apoC-III gene transcription J. Lipid Res., December 1, 2002; 43(12): 2172 - 2179. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O. Olivieri, C. Stranieri, A. Bassi, B. Zaia, D. Girelli, F. Pizzolo, E. Trabetti, S. Cheng, M. A. Grow, P. F. Pignatti, et al. ApoC-III gene polymorphisms and risk of coronary artery disease J. Lipid Res., September 1, 2002; 43(9): 1450 - 1457. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. B. Elam, H. G. Wilcox, L. M. Cagen, X. Deng, R. Raghow, P. Kumar, M. Heimberg, and J. C. Russell Increased hepatic VLDL secretion, lipogenesis, and SREBP-1 expression in the corpulent JCR:LA-cp rat J. Lipid Res., December 1, 2001; 42(12): 2039 - 2048. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. M. Dallinga-Thie, M. Groenendijk, R. N. H. H. C. Blom, T. W. A. De Bruin, and E. De Kant Genetic heterogeneity in the apolipoprotein C-III promoter and effects of insulin J. Lipid Res., September 1, 2001; 42(9): 1450 - 1456. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. C. L. Mamo, G. F. Watts, P. H. R. Barrett, D. Smith, A. P. James, and S. Pal Postprandial dyslipidemia in men with visceral obesity: an effect of reduced LDL receptor expression? Am J Physiol Endocrinol Metab, September 1, 2001; 281(3): E626 - E632. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. J. Goldberg Diabetic Dyslipidemia: Causes and Consequences J. Clin. Endocrinol. Metab., March 1, 2001; 86(3): 965 - 971. [Full Text]
|
|
|
|
 |
|
 S. V. Anisimov, M. V. Volkova, L. V. Lenskaya, V. K. Khavinson, D. V. Solovieva, and E. I. Schwartz Age-Associated Accumulation of the Apolipoprotein C-III Gene T-455C Polymorphism C Allele in a Russian Population J. Gerontol. A Biol. Sci. Med. Sci., January 1, 2001; 56(1): 27B - 32. [Abstract] [Full Text]
|
|
|
|
|
|
R. Batal, M. Tremblay, P. H. R. Barrett, H. Jacques, A. Fredenrich, O. Mamer, J. Davignon, and J. S. Cohn Plasma kinetics of apoC-III and apoE in normolipidemic and hypertriglyceridemic subjects J. Lipid Res., May 1, 2000; 41(5): 706 - 718. [Abstract] [Full Text]
|
|
|
|
|
|
Y. Kako, L.-S. Huang, J. Yang, T. Katopodis, R. Ramakrishnan, and I. J. Goldberg Streptozotocin-induced diabetes in human apolipoprotein B transgenic mice: effects on lipoproteins and atherosclerosis J. Lipid Res., December 1, 1999; 40(12): 2185 - 2194. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Reddy, W. Yang, D. G. Taylor, X.-q. Shen, D. Oxender, G. Kust, and T. Leff Mitogen-activated Protein Kinase Regulates Transcription of the ApoCIII Gene. INVOLVEMENT OF THE ORPHAN NUCLEAR RECEPTOR HNF4 J. Biol. Chem., November 12, 1999; 274(46): 33050 - 33056. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Groenendijk, R. M. Cantor, N. H. H. C. Blom, J. I. Rotter, T. W. A. de Bruin, and G. M. Dallinga-Thie Association of plasma lipids and apolipoproteins with the insulin response element in the apoC-III promoter region in familial combined hyperlipidemia J. Lipid Res., June 1, 1999; 40(6): 1036 - 1044. [Abstract] [Full Text]
|
|
|
|
|
|
R. S. Streeper, C. A. Svitek, S. Chapman, L. E. Greenbaum, R. Taub, and R. M. O'Brien A Multicomponent Insulin Response Sequence Mediates a Strong Repression of Mouse Glucose-6-phosphatase Gene Transcription by Insulin J. Biol. Chem., May 2, 1997; 272(18): 11698 - 11701. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. J. Aitman, I. F. Godsland, B. Farren, D. Crook, H. J. Wong, and J. Scott Defects of Insulin Action on Fatty Acid and Carbohydrate Metabolism in Familial Combined Hyperlipidemia Arterioscler. Thromb. Vasc. Biol., April 1, 1997; 17(4): 748 - 754. [Abstract] [Full Text]
|
|
|
|
|
|
A. P. Surguchov, G. P. Page, L. Smith, W. Patsch, and E. Boerwinkle Polymorphic Markers in Apolipoprotein C-III Gene Flanking Regions and Hypertriglyceridemia Arterioscler. Thromb. Vasc. Biol., August 1, 1996; 16(8): 941 - 947. [Abstract] [Full Text]
|
|
|
|
 |
|
 D. Kardassis, M. Laccotripe, I. Talianidis, and V. Zannis Transcriptional Regulation of the Genes Involved in Lipoprotein Transport : The Role of Proximal Promoters and Long-range Regulatory Elements and Factors in Apolipoprotein Gene Regulation Hypertension, April 1, 1996; 27(4): 980 - 1008. [Full Text]
|
|
|
|
|
|
R. H. J. B.-S. and Jacob Bar-Tana and R. Hertz Mode of Action of Peroxisome Proliferators as Hypolipidemic Drugs J. Biol. Chem., June 2, 1995; 270(22): 13470 - 13475. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. K. Hall, T. Yamasaki, T. Kucera, M. Waltner-Law, R. O'Brien, and D. K. Granner Regulation of Phosphoenolpyruvate Carboxykinase and Insulin-like Growth Factor-binding Protein-1 Gene Expression by Insulin. THE ROLE OF WINGED HELIX/FORKHEAD PROTEINS J. Biol. Chem., September 22, 2000; 275(39): 30169 - 30175. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Raspe, H. Duez, P. Gervois, C. Fievet, J.-C. Fruchart, S. Besnard, J. Mariani, A. Tedgui, and B. Staels Transcriptional Regulation of Apolipoprotein C-III Gene Expression by the Orphan Nuclear Receptor RORalpha J. Biol. Chem., January 19, 2001; 276(4): 2865 - 2871. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Journal of Biological Chemistry |
| Molecular and Cellular Proteomics | ASBMB Today |
